Remote Patient Monitoring Market to Reach $88.0 Billion by 2035 at 25% CAGR | Medtronic, Masimo, Siemens Healthineers Among Key Players

The global remote patient monitoring market, valued at $9.4 billion in 2025, is on track to reach $88.0 billion by 2035, expanding at a compound annual growth rate (CAGR) of 25% over the forecast period. This sharp growth trajectory reflects accelerating demand from healthcare systems worldwide that are under pressure to manage surging chronic disease populations while controlling costs. For investors, technology developers, and healthcare strategists, the window to establish a strong position in this market is narrowing fast.

To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/telemedicine-tools-and-software-providers-market/request-sample.html

Market Overview: Why Remote Patient Monitoring Is No Longer Optional
Remote patient monitoring (RPM) refers to the use of digital technologies, including wearable sensors, cloud-based platforms, and AI-powered analytics, to collect and transmit patient health data outside traditional clinical settings. The core value proposition is straightforward: physicians evaluate real-time data and provide treatment guidance without requiring patients to physically visit a hospital. This reduces emergency admissions, cuts unexpected expenditure, and extends care reach into geographies and demographics that are chronically underserved.

The urgency behind RPM adoption is not theoretical. According to a 2024 report from the U.S. Centers for Disease Control and Prevention, approximately 129 million Americans are currently managing at least one chronic disease. Globally, the figures are far larger, and healthcare systems in most developed and developing economies are straining under the weight of aging populations with multi-morbidities. RPM directly addresses this pressure by enabling continuous, home-based monitoring of conditions such as diabetes, hypertension, cardiovascular disease, and respiratory disorders.

Investment activity across the sector reinforces this urgency. In February 2026, Upstate Medical University received a five-year, $2.4 million state grant to expand RPM services and establish telehealth access points for home-based monitoring. That same month, Health Recovery Solutions acquired Rimidi to extend its remote care programs and deepen diabetes management capabilities. These are not isolated events; they reflect a broad pattern of capital flowing into infrastructure that makes virtual care delivery more clinically effective and commercially sustainable.

Key Growth Drivers
Rising chronic disease burden. Diabetes, cardiovascular conditions, and hypertension now affect hundreds of millions of people globally, all of whom require sustained, consistent monitoring. RPM platforms give clinicians a continuous data stream that enables early intervention, reducing costly acute episodes.

Wearable technology and AI-driven analytics. Hardware miniaturization and improved sensor accuracy have made wearable RPM devices far more reliable than earlier generations. When paired with AI and machine learning tools, these devices enable predictive analytics that move clinical care from reactive to anticipatory. Market participants are actively integrating these capabilities to differentiate their solutions.

Software as a Service adoption. Cloud-based RPM delivery is the fastest-growing software model in this market, fueled by demand for scalable, low-capital-expenditure solutions. SaaS models allow smaller healthcare providers and home-care operators to deploy sophisticated monitoring without major infrastructure investment.

Reimbursement policy clarity. Scott Laster, CEO and co-founder of MiCare Path, has noted that providers can currently receive approximately $110 to $150 per patient per month in reimbursements for RPM services. This financial clarity is a significant commercial accelerant, converting clinical interest into concrete deployment decisions.

Strategic partnerships and funding activity. Stakeholders in the RPM space have signed more than 100 collaboration agreements and collectively raised approximately $2.4 billion in capital. In March 2026, Vitalist acquired Somatix to expand its global wearable footprint and integrate medical-grade AI into its VitalOS platform. Lohman Technologies simultaneously partnered with Salvo Health to advance comprehensive remote gastrointestinal care. Deals of this nature are now routine, not exceptional.

Market Segmentation: Where the Growth Is Concentrated
The RPM market divides across software type, application area, therapeutic area, product purpose, business model, and geography. By software type, the Software as a System segment currently holds the largest share in 2025, driven by healthcare facilities that require high levels of data customization, security control, and integration with internal clinical infrastructure. Software as a Service, however, is the fastest-growing segment, benefiting from the broader shift to cloud-based healthcare delivery.

By therapeutic area, metabolic disorders account for approximately 25% of market share through 2035, reflecting the scale of global diabetes prevalence and the proven clinical utility of continuous glucose monitoring. Oncological disorders represent the fastest-growing therapeutic segment, at a CAGR of approximately 30%, because cancer patients undergoing intensive treatment face significant barriers to regular in-person clinical visits. By product purpose, the commercial segment holds around 70% of the total market, driven by adoption across fitness, wellness, and preventive care industries. Clinical-purpose RPM, though smaller, is growing at approximately 31% CAGR, signaling that hospital-grade applications are catching up quickly.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/telemedicine-tools-and-software-providers-market/request-quote.html

Regional Insights: Europe Leads, Asia-Pacific Accelerates
Europe holds the largest share of the global remote patient monitoring market, at approximately 40% through 2035. The region benefits from well-established healthcare infrastructure, strong government commitment to digital health adoption, and an ongoing policy focus on reducing per-capita care costs. National health systems across Germany, France, and the Nordic countries have been early movers in formalizing reimbursement frameworks for remote monitoring services, giving European providers a structural head start.

Asia-Pacific is the fastest-growing regional market, with a projected CAGR of approximately 30% through 2035. The growth is driven by the rapid adoption of digital health tools, including electronic health records and virtual care platforms, across major economies such as China, India, and Japan. These countries combine large patient populations with expanding middle-class healthcare demand and improving broadband and mobile connectivity, all of which are prerequisites for scaled RPM deployment. North America remains a major market driven by reimbursement policy developments and high levels of venture investment, particularly in the United States.

Competitive Landscape: A Crowded but Consolidating Field
The global RPM market currently features more than 170 active players offering software and consultation tools across a wide range of therapeutic applications. Key companies profiled in the Roots Analysis report include BioTelemetry (acquired by Philips), Masimo, Medtronic, Siemens Healthineers, LifeWatch, Braster, LeewayHertz, and Transtek Medical, among others.

The competitive dynamic is one of active consolidation through M&A alongside ongoing differentiation through technology integration. Established players are acquiring specialized startups to broaden their clinical capabilities, while newer entrants are competing on AI sophistication, device accuracy, and platform interoperability. The main battleground is no longer basic monitoring functionality; it is the quality of the insights derived from the data and the ease with which those insights connect to existing clinical workflows.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/telemedicine-tools-and-software-providers-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.